SUSQUEHANNA INTERNATIONAL GROUP, LLP - INMED PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

INMED PHARMACEUTICALS INC's ticker is and the CUSIP is 457637601. A total of 10 filers reported holding INMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of INMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,346
+45.9%
26,589
+94.5%
0.00%–
Q2 2023$12,578
-38.1%
13,672
-27.4%
0.00%–
Q1 2023$20,325–18,819–0.00%–
 Download
Other shareholders
INMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TD Waterhouse Canada Inc. 85$1250.00%
ROYAL BANK OF CANADA 11$00.00%
Advisory Services Network, LLC 6$60.00%
TCI Wealth Advisors, Inc. 5$60.00%
UBS Group AG 2,622$2,8320.00%
AllSquare Wealth Management LLC 21$230.00%
OSAIC HOLDINGS, INC. 41$430.00%
BANK OF AMERICA CORP /DE/ 1,822$1,9680.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
TORONTO DOMINION BANK 2$00.00%
View complete list of INMED PHARMACEUTICALS INC shareholders